Myocardial perfusion scintigraphy in tetralogy of fallot prior to total correction of a non-patent shunt
The Philippine Journal of Nuclear Medicine
;
: 42-44, 2010.
Article
in English
| WPRIM
| ID: wpr-632810
ABSTRACT
This paper presents a clinical situation in which a Technetium 99m sestamibi myocardial perfusion scintigraphy (MPS) with dipyridamole was used as part of the preoperative evaluation in a 15 year old female with Tetralogy of Fallot. MPS revealed no evident inducible myocardial ischemia, depressed LV wall function and RVH but with good RV function. There are many different techniques for imaging and studying patients with Tetralogy of Fallot (TOF). Echocardiography, ventriculography and invasive angiography remain the mainstay in its evaluation. However, the presence of coronary anomalies in these patients is very common and has negative effect on myocardial perfusion, either preoperatively or postoperatively. Hence, MPS plays an essential role in providing complete assessment in this group of patients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tetralogy of Fallot
/
Angiography
/
Echocardiography
/
Cerebral Ventriculography
/
Tomography, X-Ray Computed
/
Technetium Tc 99m Sestamibi
/
Myocardial Ischemia
/
Dipyridamole
/
Perfusion Imaging
/
Heart Defects, Congenital
Limits:
Adolescent
/
Female
/
Humans
Language:
English
Journal:
The Philippine Journal of Nuclear Medicine
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS